Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors

Recruiting Phase 4 Interventional Study
Intraoperative Hypotension Ciprofol Renin-angiotensin System Inhibitors
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Prevention
Participants needed
140 (estimated)
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The prevention of intraoperative hypotension could reduce postoperative organ injury and mortality, particularly in elderly patients receiving long-term renin-angiotensin system inhibitors. Previous meta-analyses suggest that ciprofol, a novel intravenous anesthetic agent, may provide improved hemodynamic stability compared to propofol; however, its precise effects on perioperative hemodynamics re…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients undergoing elective abdominal surgery under general anesthesia 2. Duration of surgery exceeding 2 hours 3. Patients receiving long-term renin-angiotensin system inhibitor therapy (\>3 months prior to surgery) 4. Age ≥ 65 years 5. ASA classification II-III 6. Informed…
Contacts

Min Yan

0571-87783759

zryanmin@zju.edu.cn

CONTACT